Merck & Co.’s extensive clinical development scheme for its TROP2 antibody-drug conjugate (ADC) sac-TMT already includes 17 global phase 3 trials. But there’s one important missing piece. The New ...

I don't like video game tutorials. They're important, don't get me wrong – I'd rather be told how to play a game than stumble through a complex control scheme – but it always feels like a chore. It is ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Sacituzumab tirumotecan significantly improved progression free survival and overall survival compared with chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

Over the last 18 months, Merck and Kelun-Biotech have notched four approvals in China for their TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT). And now, after meeting ...

Immigration and Customs Enforcement deployed an unknown number of undertrained law enforcement officers into the field because the agency’s artificial intelligence system for hiring wasn’t functioning ...

As Immigration and Customs Enforcement was racing to add 10,000 new officers to its force, an artificial intelligence error in how their applications were processed ...

Dec 15 (Reuters) - Goldman Sachs (GS.N), opens new tab is restructuring its influential technology, media, and telecom (TMT) investment banking group with an eye toward infrastructure deals and ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell lung cancer. The OptiTROP-Lung05 study is the first phase 3 trial of an ...

TMT ID, the leading mobile data and identity intelligence company, has secured a £30 million investment from BGF, the UK and Ireland’s most active growth capital investor, to support its expansion and ...

TMT officials say they remain committed to Maunakea if permitted, but also are evaluating an offer from Spain’s Canary Islands, which includes a proposed site and an investment of 400 million euros ...